Navigation Links
Exagen Launches New Diagnostic Assays for Bowel Disease at Digestive Disease Week Conference
Date:5/28/2009

Company signs partnership agreement with Clinical Reference Laboratory

ALBUQUERQUE, N.M., May 28 /PRNewswire/ -- Exagen Diagnostics, Inc. today announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Exagen will present the tests at Digestive Disease Week 2009 in Chicago, May 30 - June 4, booth #2429.

The eXaIBStest identifies patients with IBS, while the eXaIBD test identifies patients with IBD. Compared with other available laboratory tests, Exagen's assays produce significantly more accurate test results, providing physicians with more reliable data to aid in diagnosing their patients. The tests were invented using Coperna(TM), Exagen's proprietary genomic data mining software.

"Until now, physicians have relied on a wide range of tests and procedures to aid in the diagnosis of IBS and IBD, including blood tests with limited diagnostic performance," said Exagen President and CEO John Alsobrook, Ph.D. "Approximately 30 million people in the United States suffer from these diseases. Exagen's tests offer physicians several distinct diagnostic advantages, such as increased sensitivity, and we are pleased to make them readily available."

Exagen's tests are RNA-based, and require a single tube of peripheral blood. To support the front-end specimen handling and logistics, Exagen has signed a partnership agreement with Lenexa, Kansas-based Clinical Reference Laboratory (CRL), one of the nation's largest privately held clinical laboratories. This partnership enables Exagen to significantly expand its testing capacity.

"Exagen Diagnostics has developed an extremely promising series of diagnostic assays for gastrointestinal diseases," said Heather Newkirk, Ph.D., CLSp (MB), Executive Director of Molecular Diagnostics at CRL. "We welcome the opportunity to partner with them in bringing these important tests to the physician community."

About Exagen Diagnostics, Inc.

Exagen Diagnostics is a CLIA-registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. For more information, visit www.exagen.com.

About Clinical Reference Laboratory, Inc (CRL Global Services)

Established in 1979, CRL Global Services is a privately held reference laboratory in Lenexa, Kansas offering leading-edge testing services in the areas of Clinical Trials, Molecular Diagnostics, Insurance, and Toxicology. CRL is one of the largest single-site laboratories in the country and analyzes over 80 million tests annually. Additional information is available at www.crlcorp.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
2. Quick Medical Launches Medical Equipment Lease Program
3. Snoring Isn't Sexy Launches Public Awareness Campaign
4. Gyminee Raises 525K and Relaunches as DailyBurn
5. Trusted Translations Launches "Translation for St. Jude" Initiative at St. Jude Gala in New York
6. Mayo Clinic Launches Medical Science Blog
7. Transplant Expo Launches in Boston to Educate About Miracle of Transplantation and Address Organ Donor Shortage
8. National Safety Council Launches June National Safety Month With Free Training
9. PHSI Launches New Websites to Promote Sustainable Eco-Friendly Bottle-less Drinking Water Technology
10. Four Rivers Software System Launches TMS OnSite Professional
11. Health and Wellness Partners, Inc., A Wholly Owned Subsidiary of Zealous Inc., Launches Organix+
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... California (PRWEB) , ... February 10, 2016 , ... ... are working together to expand dental health services to the developmentally disabled in ... We Care Dental’s operations to a new facility at 71-949 Highway 111, Suite ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... CO (PRWEB) , ... February 10, 2016 , ... Dr. ... announce the practice is now accepting new dental patients and families in the North ... exceptional dental care services from cleanings to cosmetic dentistry, and all in the most ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of ... , As the longest running and largest worker's compensation event in Ohio, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016  CVS Health (NYSE: CVS ... in Santa Clara County, CA , ... the Santa Clara University campus. CVS Pharmacy stores and ... patients against the disease. Students at Santa Clara University ... vaccinated. In addition, anyone who has had close contact ...
(Date:2/10/2016)... 10, 2016 Immune Pharmaceuticals Inc. (NASDAQ: ... that it has filed a patent application directed to ... --> --> The ... of Ceplene (histamine dihydrochloride) in combination with immune checkpoint ... the efficacy of Ceplene and IL-2 therapy in patients ...
(Date:2/10/2016)... 10, 2016  Astellas Pharma Inc. (TSE: 4503, President ... that it has successfully completed, through its indirect wholly-owned ... purchase all issued and outstanding shares of common stock ... Paul Wotton , "Ocata") for a price of ... ("Tender Offer"). Astellas commenced the Tender Offer on November ...
Breaking Medicine Technology: